Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Трофобластические опухоли

Список литературы

  1. Мещерякова Л.А. Злокачественные трофобластические опухоли: современная диагностика, лечение и прогноз. Дис. д-ра мед. наук. М., 2005.
  2. Мещерякова Л.А., Козаченко В.П., Кузнецов В.В. Трофобластическая болезнь. Клиническая онкогинекология. Под ред. В.П. Козаченко. М.: Бином, 2016. С. 324–67.
  3. Мещерякова Л. А., Карселадзе А. И., Козаченко В. П. и др. Практические рекомен- дации по лекарственному лечению злокачественных трофобластических опухолей. Злокачественные опухоли 2018;8(3, прил.):204–12.
  4. Goto S., Yamada A., Ichisuka T. et al. Devel of postmolaropment. trophoblastic disease after partial molar pregnancy. Gynecol Oncol 2005;97:618–23.
  5. Wielsma S., Kerkmeijer I., Bekkers R. et al. Persistent trophoblastic disease following partial molar pregnancy. Aust N Z J Obstet Gynecol 2006;51:764–66.
  6. Paradinas F.J. The diagnosis and prognosis of molar pregnancy: the experience of the National Referral Centre in London. Int J Gynecol Obstet 1998;60(1):57–64.
  7. Paradinas F.J., Browne P., Fisher R.A. et al. Clinical, histopathoiogical and flowcytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopath 1996;28(2):101–9.
  8. Goto S., Yamada A., Ishisuka T., Tomoda Y. Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 1993;48(2):165–70.
  9. Bagshawe K.D., Lawler S.O., Paradinas F.J. et al. Gestational trophoblastic tumors following initial diagnosis of partial hydatidiform mole. Lancet 1990;335(8697):1074–6.
  10. Кондриков Н.И. Патология матки. М.: Практическая медицина, 2008. С. 293–305.
  11. Berkowitz R.S., Goldstein D.P.N. Chorionic tumors. Engl J Med 1996;335(23):1740–8.
  12. Soper J., Creasman W.T. Gestational Trophoblastic Neoplasia. Clinical gynecologic oncology. 7th ed. Elsever Inc., 2007. Pp. 180–220.
  13. Genest D.R., Berkowitz R., Fisber R.A. et al. Gestational trophoblastic disease. WHO classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Ed. by F.A. Tavassoli, P. Devilee. IARC, Lion, 2003. Pp. 250–254.
  14. Seckl M.J., Sebire N.J., Fisher R.A. et al. Gestational trophoblastic disease: ESMO clinical practice guidelines. Ann Oncol 2013;24(Suppl 6):39–50.
  15. Seckl M.J., Sebire H.J., Berkowitz R.S. Gestational trophoblastic disease. Lancet 2010;376(9742):717–29.
  16. FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000: FIGO Oncology Committee. Int J Gynecol Obstet 2002;77:285–7.
  17. Steigrad S.J. Epidemioligy of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 2003;17(6):837–47.
  18. Smith H.O., Kim S.J. Epidemioligy. In: Hancock B.W., Newlands E.S., Berkowitz R.L. Cole Gestational trophoblastic disease. London, 2003. Pp. 39–76.
  19. Lurain J.R. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic diseases, and management of hydatidiform mole. Am J Obstet Gynaecol 2010;203(6):531–9.
  20. Hancock B.W., Newlands E.S., Berkowitz R. et al. Gestational trophoblastic disease, online book. 2nd ed. 2003. Рp. 367–79. Available at: http://isstd.org/isstd/chapter21_files/GTD3RDCH21.pdf.
  21. Мещерякова Л.А. Алгоритм диагностики злокачественных трофобластических опухолей. Практическая онкология 2008;9(3):186.
  22. Гасанбекова З.А. Ошибки в диагностике и лечении злокачественных трофоблас- тических опухолей: Автореф. дис. канд. мед. наук. М., 2019.
  23. Gestational Trophoblastic Neoplasia. NCCN Clinical Guidelines in Oncology. Version 2. 2019 May 6.
  24. Khoo S.K., Sidhu M., Baartz D. et al. Persistence and malignant sequelae of gestational trophoblastic disease: clinical presentation, diagnosis, treatment and outcome. Aust N Z J Obstet Gynaecol 2010;50(1):81–6.
  25. Мещерякова Л.А., Карселадзе А.И., Кузнецов В.В. и др. Трофобластические опухоли. Клинические рекомендации. Под ред. М.И. Давыдова, А.В. Петровского. 2-е изд., испр. и доп. М.: Ассоциация онкологов России, 2018. С. 686–696.
  26. Мещерякова Л.А., Козаченко В.П., Чекалова М.А. и др. Трофобластическая болезнь: ошибки в диагностике и прогноз. Акушерство и гинекология 2004;4:50–5.
  27. Чекалова М.А. Ультразвуковая диагностика злокачественных заболеваний тела матки. Автореф. дис. д-ра мед. наук. М., 1999.
  28. Чекалова М.А., Зуев В.М. Ультразвуковая диагностика в онкогинекологии. М.: Русский врач, 2004. 91 с.
  29. Sita-Lumsden A., Short D., Lindsay I. et al. Treatment outcomes for 618 women with gestational trophoblastic tumors following a molar pregnancy at the Charing Cross Hospital, 2000–2009. Br J Cancer 2012;107(11):1810–4.
  30. Agarwal R., Harding V., Short D. et al. Uterine arteria pulsatilitiy index improves predictor of methotrexate resistance in gestational trophoblastic neoplasia. Br J Cancer 2012;106(6):1089–94.
  31. Тихоновская М.Н. Персистирующие трофобластические опухоли (диагностика и лечение). Автореф. дис. канд. мед. наук. М., 2015.
  32. Мещерякова Л.А. Трофобластическая болезнь и беременность. Акушерство: Национальное руководство. Под ред. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова, В.Е. Радзинского. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2018. С. 1110–23.
  33. Pezeshki M., Hancock B.W., Silcocks P. et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynaecol Oncol 2004;95(3): 423–9.
  34. Trommel N.E., Massuger L.F., Verheijen R.H. et al. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol 2005;99(1):6–13.
  35. Тихоновская М.Н. Персистирующие трофобластические опухоли (диагностика и лечение. Автореф. дис. канд. мед. наук. М., 2015.
  36. Numnum T.M., Leath C.A., Straughn J.M. et al. Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy. Gynecol Oncol 2005;97(2):713–5.
  37. Мещерякова Л.А. Стандартное лечение трофобластической болезни. Практическая онкология 2008;9(3):160–70.
  38. Мещерякова Л.А. Алгоритм лечения больных злокачественными трофобластическими опухолями. Практическая онкология 2008;9(3):187.
  39. Мещерякова Л.А., Козаченко В.П. Трофобластические опухоли: возможности хирургического лечения. Вестник РОНЦ 2003;4:36–42.
  40. Castells C.M.et al. Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases/ American Academy of Allergy, Asthma & Immunology, 2008 doi:10.1016/j.jaci.2008.02.044
  41. Hassadia A., Gillespie A., Tidy J. et al. Placental site trophoblastic tumor: clinical features and management. Gynecol Oncol 2005;99:606–7.
  42. Baergen R.N., Rutgers J.L., Young R.H. et al. Placental site trophoblastic tumor: a study of 55 cases review of literature emphasizing factors of prognostic significance. Gynecol Oncol 2006;100:511–20.
  43. Luk W.Y., Friedlander M. A fibroid or cancer? A rare case of mixed choriocarcinoma and epithelioid trophoblastic tumor. Case Report Obstet Gynaecol 2013;492754.
  44. Altman A.D., Bentley B., Murray S.et al. Maternal age-related rates of gestational trophoblastic disease. Obstet Gynaecol 2008;112(2, P. 1):244–50.
  45. Newlands E.S., Holden L., Seckl M.J. et al. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:465–71.
  46. Piura E., Piura B. Brain metastases from gestational trophoblastic neoplasia: review of pertinent literature. Eur J Gynecol Oncol 2014;35(4):359–67.
  47. Carter J. Fast-track surgery in gynaecology and gynaecologic oncology: a review of a rolling clinical audit. ISRN Surgery 2012;2012:368014.
  48. Nelson G., Bakkum-Gamez J., Kalogera E. et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations – 2019. Int J Gynecol Cancer 2019;29(4):651–68.
  49. De Almeida E.P.M., de Almeida J.P., Landoni G. et al. Early mobilization programme improves functional capacity after major abdominal cancer surgery: a randomized controlled trial. Br J Anaesth 2017;119(5):900–7.
  50. Wren S.M., Martin M., Yoon J.K. et al. Postoperative pneumonia-prevention program for the inpatient surgical ward. Journal of the American College of Surgeons 2010;210(4):491– 5.
  51. Peedicayil A., Weaver A., Li X. et al. Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol 2011;121(1):64–9.
  52. Cantrell LA et. al. Thrombosis and Thromboprophylaxis in Gynecology Surgery. / Clin Obstet Gynecol. 2018 Jun;61(2):269-277. doi: 10.1097/GRF.0000000000000355.
  53. Swarm R., Abernethy A.P., Anghelescu D.L. et al. NCCN Adult Cancer Pain. Adult cancer pain. J Natl Compr Canc Netw 2010;8:1046–86.
  54. Ben-Arye E., Samuels N., Lavie O. Integrative medicine for female patients with gynecologic cancer. J Altern Complement Med 2018;24:881–9.
  55. Goerling U., Jaeger C., Walz A. et al. The efficacy of psycho-oncological interventions for women with gynaecological cancer: a randomized study. Oncology 2014;87:114–24.
  56. Smits A., Lopes A., Bekkers R. et al. Body mass index and the quality of life of endometrial cancer survivors – a systematic review and meta-analysis. Gynecol Oncol 2015;137:180–7.
  57. Schmitz K.H., Courneya K.S., Matthews C. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409–26.
  58. Zhou Y., Chlebowski R., LaMonte M.J. et al. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women"s Health Initiative. Gynecol Oncol 2014;133(1):4–10.
  59. Bifulco G et al. Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers./ Gynecol Oncol. 2012 Mar;124(3):444-51. doi: 10.1016/j.ygyno.2011.11.033. Epub 2011 Nov 23.
  60. Goerling U., Jaeger C., Walz A. et al. The efficacy of psycho-oncological interventions for women with gynaecological cancer: A randomized study // Oncology. 2014;87:114–124. Crossref, Medline .
  61. Dumoulin C., Cacciari L.P., Hay‐Smith E.J.C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018:10:CD005654.
  62. Cannioto R.A., Moysich K.B. Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription. Gynecol Oncol 2015;137(3):559–73.
  63. Hu M., Lin W. Effects of exercise training on red blood cell production: implications for anemia. Acta Haematol 2012;127(3):156–64.
  64. Mustian K.M., Alfano C.M., Heckler C. et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol 2017;3:961–8.
  65. Kinkead B., Schettler P.J., Larson E.R. et al. Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial. Cancer 2018;124(3):546–54.
  66. Streckmann F., Zopf E.M., Lehmann H.C. et al. Exercise intervention studies in patients with peripheral neuropathy: a systematic review. Sports Med 2014;44:1289–304.
  67. Kleckner I.R., Kamen C., Gewandter J.S. et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 2018;26:1019–28.
  68. Muzi J.L., Look R.M., Turner C. et al. Low-level laser therapy for chemotherapy-induced peripheral neuropathy. J Clin Oncol 2012;30(15):9019.
  69. Rick O., von Hehn U., Mikus E. et al. Magnetic field therapy in patients with cytostatics- induced polyneuropathy: A prospective randomized placebo-controlled phase-III study. Bioelectromagnetics 2016;38(2):85–94.
  70. Kılınç M., Livanelioğlu A., Yıldırım S.A., Tan E. Effects of transcutaneous electrical nerve stimulation in patients with peripheral and central neuropathic pain. J Rehabil Med 2014;46(5):454–60.
  71. Oberoi S., Zamperlini-Netto G., Beyene J., Treister N.S., Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014;9(9):e107418.
  72. Ross M., Fischer-Cartlidge E. Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia. Clin J Oncol Nurs 2017;21(2):226–33.
  73. Spence R.R., Heesch K.C., Brown W.J. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev 2010;36(2):185–194.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*